Coulson Aviation today introducedCFR HALO, a next-generation long-term fire retardant engineered specifically for modern aircraft, tank systems, and wildfire missions. It is the first product from Coulson EmberWorks, the company’s research and development...

SES S.A. announces financial results for the three and six months ended...

Kioxia Corporation, a world leader in memory solutions, today announced it has commenced sample shipments of 1Tb (terabit) Triple-Level Cell (TLC) memory devices incorporating its 9th-generation BiCS FLASH™ 3D flash memory technology1. The devices are designed to support applications such as AI-enabled PCs and smartphones...

Media OutReach...

Media OutReach...

Media OutReach...

Toshiba Electronic Devices & Storage Corporation("Toshiba") has started mass production of TXZ+™ Family Entry‑ClassM4L Group, compact microcontrollers featuring an Arm® Cortex®‑M4 core with a floating‑point unit (FPU) for next-generation home...

Media OutReach...

Phase 2 upgrade drilling nearing completion, with...

TORONTO, ON /ACCESS Newswire/ July 29, 2026 /Blueberries Medical Corp. (CSE:BBM)(OTCID:BBRRF)(FRA:1OA) (the "Company" or "Blueberries"), a consumer science company focused on health, wellness and longevity, and a licensed producer of both psychoactive and non-psychoactive cannabis derivatives in Colombia, is pleased to announce a non-brokered private placement consisting of the sale of 84,615,385 common shares ("Common Shares") at a price of C$0.013 per Common Share for aggregate gross proceeds of approximately C$1.1 million (or approximately US$781,000) (the "Offering"). The net proceeds from the sale of the Common Shares are expected to fund and...